Nature | News

‘Web of Science’ to be sold to private-equity firms

Thomson Reuters divests intellectual-property and science division in US$3.55-billion deal.

Article tools

Rights & Permissions

The vast science-citation database ‘Web of Science’ will be sold by its long-time owner, Thomson Reuters, as part of a US$3.55-billion divestment of the firm’s intellectual-property and science division.

The deal, according to an announcement on 11 July, will transfer the division to private equity funds affiliated with Onex Corporation, based in Toronto, and Baring Private Equity Asia, headquartered in Hong Kong. But industry observers expect that the new owners will later break up the division and resell its parts for a profit.

Thomson Reuters, a multinational news and information company, had long been expected to part with the division, which employs some 3,200 people, to focus on its core businesses of financial, trade and regulatory information.

“Private-equity groups only buy something when they have an idea of how they will resell it later,” says Joseph Esposito, who heads Processed Media, an academic and professional publishing consultancy in New York City, and who is a former chief executive of the Encyclopaedia Britannica.

Esposito speculates that the equity funds have calculated that the expansion of science and innovation in Asia makes the businesses ripe for growth, and so for reselling — in particular, Thomson Reuters’s patent databases, such as the Derwent World Patents Index. “We should not be surprised to find that some pieces of the new acquisition get spun off,” he says.

Any future owner of the division’s science-metrics products, which include the subscription-based platforms Web of Science and Journal Citation Reports, is unlikely to change them much or to innovate, as these services are already mature and profitable stand-alone products, predicts Esposito: “They are cash cows.”

The sale, which is subject to approval by regulatory authorities, has also sparked speculation over who might eventually end up buying the products from their private-equity owners. David Worlock, an independent UK-based publishing consultant, speculates that Nature’s parent company, Springer Nature, might be one potential suitor. The company says that it has no comment to make.

Yvonne Nobis, head of science-information services at the the Betty & Gordon Moore Library at the University of Cambridge, UK, suggests a more radical option. “Should the academic community buy @webofscience ? We need metrics to be publisher neutral,” she tweeted.

Journal name:

For the best commenting experience, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will see comments updating in real-time and have the ability to recommend comments to other users.


Commenting is currently unavailable.

sign up to Nature briefing

What matters in science — and why — free in your inbox every weekday.

Sign up



Nature Podcast

Our award-winning show features highlights from the week's edition of Nature, interviews with the people behind the science, and in-depth commentary and analysis from journalists around the world.